708 related articles for article (PubMed ID: 16641862)
1. Treatment options of polycystic ovary syndrome in adolescence.
Zapanti E; Kiapekou E; Loutradis D
Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():208-13. PubMed ID: 16641862
[TBL] [Abstract][Full Text] [Related]
2. Treatment of PCOS in adolescence.
Warren-Ulanch J; Arslanian S
Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):311-30. PubMed ID: 16772160
[TBL] [Abstract][Full Text] [Related]
3. Endocrine characteristics of polycystic ovary syndrome (PCOS).
Szilágyi A; Szabó I
Indian J Exp Biol; 2003 Jul; 41(7):694-700. PubMed ID: 15255372
[TBL] [Abstract][Full Text] [Related]
4. [Advance in treatment of polycystic ovary syndrome].
Krysiak R; Okopień B; Herman ZS
Pol Merkur Lekarski; 2005 Dec; 19(114):848-54. PubMed ID: 16521439
[TBL] [Abstract][Full Text] [Related]
5. [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
Svendsen PF; Nilas L; Nørgaard K; Madsbad S
Ugeskr Laeger; 2005 Aug; 167(34):3147-51. PubMed ID: 16117910
[TBL] [Abstract][Full Text] [Related]
6. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
Otto-Buczkowska E; Jarosz-Chobot P; Deja G
Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Syndrome: Polycystic Ovary Syndrome.
Mortada R; Williams T
FP Essent; 2015 Aug; 435():30-42. PubMed ID: 26280343
[TBL] [Abstract][Full Text] [Related]
8. Polycystic ovary syndrome.
Kahn JA; Gordon CM
Adolesc Med; 1999 Jun; 10(2):321-36. PubMed ID: 10370713
[TBL] [Abstract][Full Text] [Related]
9. Polycystic ovary syndrome in adolescents.
Kent SC; Legro RS
Adolesc Med; 2002 Feb; 13(1):73-88, vi. PubMed ID: 11841956
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic therapy of polycystic ovary syndrome.
Dronavalli S; Ehrmann DA
Clin Obstet Gynecol; 2007 Mar; 50(1):244-54. PubMed ID: 17304039
[TBL] [Abstract][Full Text] [Related]
11. The effect of pharmaceutical intervention on lipid profile in polycystic ovary syndrome.
Diamanti-Kandarakis E; Kandaraki E; Christakou C; Panidis D
Obes Rev; 2009 Jul; 10(4):431-41. PubMed ID: 19413702
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovary syndrome in the Indian Subcontinent.
Allahbadia GN; Merchant R
Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
[TBL] [Abstract][Full Text] [Related]
14. PCOS in adolescents.
Diamanti-Kandarakis E
Best Pract Res Clin Obstet Gynaecol; 2010 Apr; 24(2):173-83. PubMed ID: 19932060
[TBL] [Abstract][Full Text] [Related]
15. Obesity and the polycystic ovary syndrome.
Martínez-Bermejo E; Luque-Ramírez M; Escobar-Morreale HF
Minerva Endocrinol; 2007 Sep; 32(3):129-40. PubMed ID: 17912153
[TBL] [Abstract][Full Text] [Related]
16. Prevention of diabetes and cardiovascular disease in women with PCOS: treatment with insulin sensitizers.
Sharma ST; Nestler JE
Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):245-60. PubMed ID: 16772155
[TBL] [Abstract][Full Text] [Related]
17. Adolescent polycystic ovary syndrome.
Connor EL
Adolesc Med State Art Rev; 2012 Apr; 23(1):164-77, xii. PubMed ID: 22764561
[TBL] [Abstract][Full Text] [Related]
18. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.
Genazzani AD; Lanzoni C; Ricchieri F; Baraldi E; Casarosa E; Jasonni VM
Gynecol Endocrinol; 2007 Mar; 23(3):146-52. PubMed ID: 17454168
[TBL] [Abstract][Full Text] [Related]
19. Effects of the insulin sensitizer pioglitazone on menstrual irregularity, insulin resistance and hyperandrogenism in young women with polycystic ovary syndrome.
Stabile G; Borrielli I; Artenisio AC; Bruno LM; Benvenga S; Giunta L; La Marca A; Volpe A; Pizzo A
J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):177-82. PubMed ID: 24814528
[TBL] [Abstract][Full Text] [Related]
20. Use of insulin sensitizers in polycystic ovarian syndrome.
Baillargeon JP
Curr Opin Investig Drugs; 2005 Oct; 6(10):1012-22. PubMed ID: 16259222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
